In Vitro and In Vivo BE Approaches: Challenges and Opportunities - Session 3A
Рет қаралды 2,280
Күн бұрынPresentations and a panel consider the utility of in vitro characterization and modeling approaches to support biowaivers for certain non-Q1/Q2 formulations of prospective generic products. Presentations include, “Mechanistic Assessment of Excipient Changes for Biopharmaceutics Classification System (BCS) 1 Class and 3 Drug Products” and “BCS Class 3 Compounds: In Vivo Experience with Non-Q1/Q2 Formulations.”
Learn more at: www.fda.gov/dr...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training - www.fda.gov/cd...
SBIA Listserv - public.govdeli...
SBIA 2021 Playlist - • 2021 CDER Small Busine...
SBIA LinkedIn: / cder-small-business-an...
SBIA Training Resources - www.fda.gov/cd...
Twitter - / fda_drug_info
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367
U.S. Food and Drug Administration
Рет қаралды 510
Harley Quinn with the Joker
Рет қаралды 26 МЛН
I migliori trucchetti di Fabiosa
Рет қаралды 12 МЛН
U.S. Food and Drug Administration
Рет қаралды 2,2 М.
U.S. Food and Drug Administration
Рет қаралды 172
U.S. Food and Drug Administration
Рет қаралды 107
U.S. Food and Drug Administration
Рет қаралды 1,6 М.
U.S. Food and Drug Administration
Рет қаралды 942
U.S. Food and Drug Administration
Рет қаралды 1,2 М.
U.S. Food and Drug Administration
Рет қаралды 507
U.S. Food and Drug Administration
Рет қаралды 1,1 М.
U.S. Food and Drug Administration
Рет қаралды 656
Harley Quinn with the Joker
Рет қаралды 26 МЛН